Atlas Trials

Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea

Clinical trial NCT01929291 · COMPLETED

Trial details

NCT number
NCT01929291
Sponsor
GlaxoSmithKline
Status
COMPLETED
Study type
OBSERVATIONAL
Diphtheria-Tetanus-acellular Pertussis Vaccines
Start date
2013-09-23
Primary completion
2016-01-11
Enrollment
682

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.